Spontaneous remission from a terminal prognosis

BMY             recently has had poor lung cancer treatment results and is getting sold off, movement compounded by Mercks recent promising results in the the same treatment field. Today was another huge down day, with a push past 3 standard deviations according to a 20 day closing Bollinger Band . Long because On Balance Volume has been improving while the price has been falling, and it might be at a short term reversal. In at 49.91 with a target of 5% or 52.40 from an anticipated short term correction tomorrow. Price is holding in this range with a low of 49.72, and high of 51.30 for the day.
Comment: Might be worth holding until earnings, Low projections of 48 with highs of 67 and even 100.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out